SonoScape Medical Announces the Release of S-Fetus 4.0 to Simplify Sonography Process

SonoScape Medical Corp. today announced the release of S-Fetus 4.0, the latest software upgrade of the company’s flagship ultrasound product offering. This technical breakthrough marks S-Fetus 4.0 as the globally first smart obstetric screening technology based on deep learning.

Leveraging the deep learning techniques, the S-Fetus 4.0 Obstetric Screening Assistant allows doctors to automatically acquire standard planes and measure fetal biometry with fast performance and accuracy. Without the need for manually repetitive operation of the device, the system was designed with one-click simple touch to streamline the sonogram pocess and improve scanning efficiency. “Our obstetric screening assistant has achieved breakthroughs in terms of performance and scalability and now it can offer more efficient means of smart obstetric diagnosis that assist doctors in precise work to ensure better patient outcomes”, said Zhou Guoyi, Head of SonoScape Medical Innovation Research Center.

To improve service capability, SonoScape applied this newly upgrade to a variety of high-end ultrasound equipment. The S-Fetus 4.0 is going to run on SonoScape S60, P60, P60 Exp, S50 Elite, P50 Elite and P40 Elite, both in the North America and ROW Region. “With our commitment to the independent R&D and innovation of medical equipment, our cutting edge technology has been able to realize its potential to serve medical institutions around the world”, commented Naizhang Feng, Vice President of SonoScape Ultrasound Division.

The S-Fetus 4.0 Obstetric Screening Assistant is powered by Intel® oneAPI Toolkits.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”